New Cardiovascular Drugs To Watch
Heart attacks and strokes are the leading killers in America, taking nearly 1 million lives annually. Not surprisingly, treatments for cardiovascular disease are big money for drug companies. In 2002, cholesterol-lowering pills alone accounted for $22 billion in global sales. In September, we pinpointed five promising cardiovascular drugs--all of which seem to be gaining steam (click here for our complete cardiovascular drug watch list). But over the last four months, drug companies have unveiled a pharmacopoeia of promising new compounds. Click on the image below to learn about the five new cardiovascular treatments we have added to our watch list.